Specialty
Anesthesiology & Respiratory devices
Last checked: Nov 19, 2026Source: openFDA and ClinicalTrials.govMethods & limitations
FDA decisions since 2015
1,034
510(k), De Novo and PMA
Decisions, last 36 months
283
Recruiting device trials
108
Industry sponsored
Adverse event reports
175,434
Received Nov 1, 2025 to Nov 19, 2026
Narrower views
Latest FDA decisions
The 8 newest. A specialty is the FDA review panel, or a list of product codes for a narrower view.
- Model 7000 Spirotrac510(k)
K260990 · Decided Nov 4, 2026 · 224 days after receipt
Device type: Spirometer, Diagnostic (BZG) · Anesthesiology & Respiratory
K253095 · Decided Oct 30, 2026 · 402 days after receipt
Device type: Apparatus, Nitric Oxide Delivery (MRN) · Anesthesiology & Respiratory
- RP Check (RP01)510(k)
K260671 · Decided Oct 26, 2026 · 238 days after receipt
Device type: Monitor, Airway Pressure (Includes Gauge And/Or Alarm) (CAP) · Anesthesiology & Respiratory
Suzhou Yuyue Medical Technology Co., Ltd.
K260251 · Decided Oct 23, 2026 · 269 days after receipt
Device type: Ventilator, Non-Continuous (Respirator) (BZD) · Anesthesiology & Respiratory
Xiamen Compower Medical Tech. Co., Ltd.
K263254 · Decided Oct 16, 2026 · 29 days after receipt
Device type: Ventilator, Emergency, Manual (Resuscitator) (BTM) · Anesthesiology & Respiratory
- Helo Return510(k)
Endovascular Engineering, Inc.
K253717 · Decided Oct 11, 2026 · 321 days after receipt
Device type: Thrombectomy Whole Blood Return System (SHJ) · Anesthesiology & Respiratory
- Glucommander510(k)
K261939 · Decided Oct 5, 2026 · 117 days after receipt
Device type: Calculator, Drug Dose (NDC) · Anesthesiology & Respiratory
K260140 · Decided Sep 25, 2026 · 248 days after receipt
Device type: Abnormal Breath Sound Device (PHZ) · Anesthesiology & Respiratory
FDA decisions per month
Last 36 months, by decision date and pathway.
- 510(k)
- De Novo
- PMA
View as table
| Month | 510(k) | De Novo | PMA |
|---|---|---|---|
| Dec 23 | 7 | 0 | 0 |
| Jan 24 | 2 | 1 | 0 |
| Feb 24 | 6 | 1 | 0 |
| Mar 24 | 4 | 0 | 0 |
| Apr 24 | 3 | 0 | 0 |
| May 24 | 9 | 0 | 0 |
| Jun 24 | 7 | 0 | 0 |
| Jul 24 | 6 | 0 | 0 |
| Aug 24 | 10 | 0 | 0 |
| Sep 24 | 10 | 0 | 0 |
| Oct 24 | 5 | 1 | 1 |
| Nov 24 | 9 | 0 | 0 |
| Dec 24 | 18 | 0 | 1 |
| Jan 25 | 8 | 0 | 0 |
| Feb 25 | 5 | 0 | 0 |
| Mar 25 | 4 | 0 | 0 |
| Apr 25 | 8 | 0 | 0 |
| May 25 | 8 | 0 | 0 |
| Jun 25 | 14 | 0 | 0 |
| Jul 25 | 9 | 0 | 0 |
| Aug 25 | 13 | 0 | 1 |
| Sep 25 | 8 | 0 | 0 |
| Oct 25 | 4 | 0 | 0 |
| Nov 25 | 4 | 0 | 0 |
| Dec 25 | 14 | 0 | 0 |
| Jan 26 | 6 | 0 | 0 |
| Feb 26 | 2 | 0 | 0 |
| Mar 26 | 7 | 0 | 1 |
| Apr 26 | 10 | 0 | 0 |
| May 26 | 13 | 0 | 0 |
| Jun 26 | 12 | 1 | 0 |
| Jul 26 | 6 | 0 | 0 |
| Aug 26 | 8 | 0 | 0 |
| Sep 26 | 9 | 0 | 0 |
| Oct 26 | 6 | 0 | 0 |
| Nov 26 | 1 | 0 | 0 |
Recruiting device trials
Industry-sponsored device trials that are recruiting now, most recently updated first.
Aether Tech S.L.Not on our public-company list
NCT07938086 · 24 participants (planned) · Start Apr 15, 2026 · Primary completion Dec 20, 2026
Device: EMILY.AI automatic oxygen titration · For: Chronic Obstructive Pulmonary Disease (COPD); Interstitial Lung Diseases; Pulmonary Hypertension and 1 more
Sites: Madrid, Spain
- KPAP vs EPR for ComfortRecruiting
SleepRes Inc.Not on our public-company list
NCT07530510 · 24 participants (planned) · Start Nov 1, 2026 · Primary completion Jul 1, 2027
Device: APAP + KPAP; APAP + EPR · For: Obstructive Sleep Apnea
Sites: Murfreesboro, Tennessee
Acurable Ltd.Not on our public-company list
NCT04031950 · 345 participants (planned) · Start Feb 19, 2020 · Primary completion Oct 14, 2027
Device: Novel wearable paediatric device · For: Sleep Apnea
Sites: Sheffield, United Kingdom; Southampton, United Kingdom
- LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLCPivotal-lookingRecruiting
NovoCure GmbHNot on our public-company list
NCT06216301 · 734 participants (planned) · Start Jul 31, 2024 · Primary completion Oct 2028
Device: NovoTTF-200T · For: Metastatic Non-small Cell Lung Cancer
Sites: Birmingham, Alabama; Goodyear, Arizona; Fullerton, California · 107 sites in all
Cook Research IncorporatedNot on our public-company list
NCT05881798 · 82 participants (planned) · Start Jun 2, 2025 · Primary completion Oct 2027
Device: Celect Platinum Vena Cava Filter · For: Deep Vein Thrombosis; Venous Thromboembolism; Pulmonary Embolism
Sites: Los Angeles, California; Barcelona, Spain; Córdoba, Spain · 7 sites in all
- A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary FibrosisPivotal-lookingRecruiting
Rein TherapeuticsNot on our public-company list
NCT06968845 · 120 participants (planned) · Start Feb 2, 2026 · Primary completion Sep 30, 2027
Device: Dry Powder Inhaler · For: Idiopathic Pulmonary Fibrosis (IPF)
Sites: Birmingham, Alabama; Los Angeles, California; San Diego, California · 48 sites in all
How new technology gets paid for
Recent Medicare coverage decisions that touch this specialty.
Reports received
175,434
Received Nov 1, 2025 to Nov 19, 2026. Includes 224 of another or unstated type.
Malfunction reports
172,669
98% of reports
Injury reports
2,198
1.3% of reports
Death reports
343
0.2% of reports
Adverse event reports received per month
By the date FDA received each report. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Nov 25 | 19,181 | 189 | 57 | 0 |
| Dec 25 | 9,821 | 135 | 50 | 1 |
| Jan 26 | 9,512 | 148 | 34 | 0 |
| Feb 26 | 14,793 | 152 | 37 | 0 |
| Mar 26 | 16,850 | 162 | 40 | 0 |
| Apr 26 | 9,412 | 245 | 23 | 0 |
| May 26 | 14,112 | 149 | 10 | 1 |
| Jun 26 | 20,057 | 184 | 26 | 1 |
| Jul 26 | 21,674 | 172 | 14 | 16 |
| Aug 26 | 14,108 | 185 | 15 | 94 |
| Sep 26 | 12,199 | 292 | 20 | 63 |
| Oct 26 | 10,950 | 185 | 17 | 48 |
| Nov 26 | 0 | 0 | 0 | 0 |
Device types with the most reports
Widely used device types get more reports. This is not a ranking of safety.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.